These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25895667)

  • 1. Translocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints.
    Yamamoto K; Kawamoto S; Kakiuchi S; Yakushijin K; Matsuoka H; Minami H
    Acta Haematol; 2015; 134(2):76-9. PubMed ID: 25895667
    [No Abstract]   [Full Text] [Related]  

  • 2. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).
    Launay E; Henry C; Meyer C; Chappé C; Taque S; Boulland ML; Ben Abdelali R; Dugay F; Marschalek R; Bastard C; Fest T; Gandemer V; Belaud-Rotureau MA
    Leuk Lymphoma; 2014 Mar; 55(3):662-7. PubMed ID: 23725386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).
    Wang Y; Li W; Chen S; Qiu H; Sun A; Wu D
    Leuk Res; 2011 May; 35(5):604-7. PubMed ID: 21130493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
    Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
    [No Abstract]   [Full Text] [Related]  

  • 6. Translocation t(1;11)(q21;q23): a new finding in congenital acute myeloid leukemia.
    Reynaert N; Vandenberghe P; Boeckx N; Renard M; Uyttebroeck A; Labarque V
    Leuk Lymphoma; 2014 Jun; 55(6):1435-6. PubMed ID: 24001130
    [No Abstract]   [Full Text] [Related]  

  • 7. A cryptic three-way translocation t(10;19;11)(p12.31;q13.31;q23.3) with a derivative Y-chromosome in an infant with acute myeloblastic leukemia (M5b).
    Othman MA; Vujić D; Zecević Z; Đurišić M; Slavković B; Meyer B; Liehr T
    Gene; 2015 Jun; 563(2):115-9. PubMed ID: 25725124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].
    Chen L; Wei XD; Yin QS
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):484-6. PubMed ID: 22967387
    [No Abstract]   [Full Text] [Related]  

  • 9. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S; Mellink CH; van der Lelie H
    Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloblastic leukemia in a patient with hereditary protein C deficiency.
    Matsui K; Tanaka Y; Yamashita K; Matsuda K; Shinohara K
    Intern Med; 2006; 45(11):729-32. PubMed ID: 16819254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome of CAG regimen in 26 children with aucte myeloid leukemia].
    Chen X; Ruan M; Liu F; Liu TF; Chen XJ; Guo Y; Zhang L; Yang WY; Chang LX; Zhao BB; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):594-596. PubMed ID: 32397024
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
    Duhoux FP; De Wilde S; Ameye G; Bahloula K; Medves S; Légé G; Libouton JM; Demoulin JB; A Poirel H
    Leuk Res; 2011 Mar; 35(3):e18-20. PubMed ID: 20980053
    [No Abstract]   [Full Text] [Related]  

  • 13. De novo acute myeloblastic leukemia with trilineage abnormalities and a t(3;12) in a child.
    Hazard E; Bastard C; Callat MP; Schneider P; Vannier JP
    Med Pediatr Oncol; 2003 Jun; 40(6):397-400. PubMed ID: 12692813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Curative effect of low dose cytarabine and aclarubin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on patients with the intermediate and high-risk myelodysplastic syndrome].
    Zhu Y; He Y; Chen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):370-3. PubMed ID: 20448361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia].
    Zu Y; Zhang Y; Zhou J; Zhao H; Gui R; Li Z; Li M; Wei X; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):334-6. PubMed ID: 27093999
    [No Abstract]   [Full Text] [Related]  

  • 16. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
    de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
    Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
    Lu H; Lu SF; Shen WY; Hong M; Zhang JF; Wang LX; Yang H; Li JY
    Leuk Res; 2008 Nov; 32(11):1776-9. PubMed ID: 18501425
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations].
    Wang B; Yang B; Dong W; Liu D; Ling Y; Cao X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):653-5. PubMed ID: 25052613
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation.
    Chen SS; Sun Q; Cao L; Wu WZ; Xie Y; Qiao C; Li JY; Qian SX; Hong M
    Chin Med J (Engl); 2020 Dec; 134(12):1477-1479. PubMed ID: 33323826
    [No Abstract]   [Full Text] [Related]  

  • 20. Translocation between chromosome 5q35 and chromosome 11q13-- an unusual cytogenetic finding in a primary refractory acute myeloid leukemia.
    Wang TF; Horsley SW; Lee KF; Chu SC; Li CC; Kao RH
    Clin Lab Haematol; 2006 Jun; 28(3):160-3. PubMed ID: 16706931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.